{"SPADE_N_07383": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_07383", "Peptide Name": "Lasso peptide Felipeptin A2", "Source": "Bacteria", "Family": "", "Gene": "Not found", "Sequence": "GGGGRGYEYNKQCLIFC", "Sequence Length": 17, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C81H121N23O24S2", "Mass": 1865.1, "PI": 8.03, "Net Charge": 1, "Hydrophobicity": -0.44, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Class IV Lasso Peptides Synergistically Induce Proliferation of Cancer Cells and Sensitize Them to Doxorubicin", "Pubmed ID": "33294793", "Reference": "iScience. 2020 Nov 10;23(12)101786.", "Author": "Guerrero-Garzón JF, Madland E, Zehl M, Singh M, Rezaei S, Aachmann FL, Courtade G, Urban E, Rückert C, Busche T, Kalinowski J, Cao YR, Jiang Y, Jiang CL, Selivanova G, Zotchev SB.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=33294793"}], "Frequent Amino Acids": "GCY", "Absent Amino Acids": "ADHMOPSTUVW", "Basic Residues": 2, "Acidic Residues": 1, "Hydrophobic Residues": 5, "Polar Residues": 8, "Positive Residues": 2, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_01709", "Similarity": 1.0, "Sequence": "GGGG"}, {"SPADE_ID": "SPADE_UN_08791", "Similarity": 1.0, "Sequence": "GGGG"}, {"SPADE_ID": "SPADE_UN_08792", "Similarity": 1.0, "Sequence": "GGGGG"}]}}}